Tirzepatide 20 mg 90 Day Protocol
High-quality injectable solution for medical use
$1699.00
Tirzepatide is a novel dual agonist peptide targeting both the GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. Tirzepatide is the first compound in a new class known as “twincretins.” Its discovery represents a major advancement in metabolic peptide therapeutics, combining two endogenous incretin pathways to produce superior effects on glycemic control and weight loss. superior quality with Tirzepatide 20mg/vial, expertly developed by DNAxis for advanced medical research and clinical applications.
Each clear glass vial contains 20mg of high-purity Tirzepatide, ensuring consistent and reliable results. Ideal for laboratories and healthcare professionals seeking cutting-edge solutions, this product comes securely sealed to preserve potency. Dimensions: 10ml vial; color: transparent with a blue cap. Elevate your research and achieve breakthrough outcomes with Tirzepatide.
No Refunds Policy – Peptide Orders
All peptide sales are final. Due to the sensitive nature of research peptides, we cannot accept returns or issue refunds once an order has been placed. This policy ensures product integrity, safety, and compliance. Please review your order carefully before completing your purchase.